CNS White Matter Disorders
Clinical Pathology
>
Neurology & Psychiatry
>
CNS Demyelinating Disorders
Q. A patient with multiple sclerosis is taking natalizumab. She develops a progressive illness consisting of hemianopia, ataxia, and encephalopathy. Which of the following should be your primary concern?
a
The natalizumab has failed to control her multiple sclerosis.
b
She is converting from multiple sclerosis to Neuromyelitis optica (NMO).
c
She is converting from multiple sclerosis to acute disseminated encephalomyelitis (ADEM)
d
She has developed a JC virus infection of oligodendrocytes.
Log In
or
Start Your Free Trial
to view the answer.